Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCPGC vs Neulasta in Chemotherapy-induced Neutropenia
NCT01328938Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Oct 2010
- Primary completion
- Nov 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of pegteograstim in neutropenia, sponsored by GC Biopharma. Started Oct 2010; status: completed.
02
Drugs
pegteograstim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01328938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328938.